IBDEI0E3 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6146,1,3,0)
 ;;=3^Neuromuscular Dysfunction of Bladder,Unspec
 ;;^UTILITY(U,$J,358.3,6146,1,4,0)
 ;;=4^N31.9
 ;;^UTILITY(U,$J,358.3,6146,2)
 ;;=^5015648
 ;;^UTILITY(U,$J,358.3,6147,0)
 ;;=N31.0^^40^384^36
 ;;^UTILITY(U,$J,358.3,6147,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6147,1,3,0)
 ;;=3^Uninhibited Neuropathic Bladder NEC
 ;;^UTILITY(U,$J,358.3,6147,1,4,0)
 ;;=4^N31.0
 ;;^UTILITY(U,$J,358.3,6147,2)
 ;;=^5015644
 ;;^UTILITY(U,$J,358.3,6148,0)
 ;;=N35.9^^40^384^37
 ;;^UTILITY(U,$J,358.3,6148,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6148,1,3,0)
 ;;=3^Urethral Stricture,Unspec
 ;;^UTILITY(U,$J,358.3,6148,1,4,0)
 ;;=4^N35.9
 ;;^UTILITY(U,$J,358.3,6148,2)
 ;;=^5015671
 ;;^UTILITY(U,$J,358.3,6149,0)
 ;;=N39.0^^40^384^35
 ;;^UTILITY(U,$J,358.3,6149,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6149,1,3,0)
 ;;=3^UTI,Unspec Site
 ;;^UTILITY(U,$J,358.3,6149,1,4,0)
 ;;=4^N39.0
 ;;^UTILITY(U,$J,358.3,6149,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,6150,0)
 ;;=R31.9^^40^384^21
 ;;^UTILITY(U,$J,358.3,6150,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6150,1,3,0)
 ;;=3^Hematuria,Unspec
 ;;^UTILITY(U,$J,358.3,6150,1,4,0)
 ;;=4^R31.9
 ;;^UTILITY(U,$J,358.3,6150,2)
 ;;=^5019328
 ;;^UTILITY(U,$J,358.3,6151,0)
 ;;=R31.0^^40^384^20
 ;;^UTILITY(U,$J,358.3,6151,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6151,1,3,0)
 ;;=3^Gross Hematuria
 ;;^UTILITY(U,$J,358.3,6151,1,4,0)
 ;;=4^R31.0
 ;;^UTILITY(U,$J,358.3,6151,2)
 ;;=^5019325
 ;;^UTILITY(U,$J,358.3,6152,0)
 ;;=R31.1^^40^384^1
 ;;^UTILITY(U,$J,358.3,6152,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6152,1,3,0)
 ;;=3^Benign Essential Microscopic Hematuria
 ;;^UTILITY(U,$J,358.3,6152,1,4,0)
 ;;=4^R31.1
 ;;^UTILITY(U,$J,358.3,6152,2)
 ;;=^5019326
 ;;^UTILITY(U,$J,358.3,6153,0)
 ;;=R31.2^^40^384^28
 ;;^UTILITY(U,$J,358.3,6153,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6153,1,3,0)
 ;;=3^Microscopic Hematuria NEC
 ;;^UTILITY(U,$J,358.3,6153,1,4,0)
 ;;=4^R31.2
 ;;^UTILITY(U,$J,358.3,6153,2)
 ;;=^5019327
 ;;^UTILITY(U,$J,358.3,6154,0)
 ;;=N40.0^^40^384^6
 ;;^UTILITY(U,$J,358.3,6154,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6154,1,3,0)
 ;;=3^Enlarged Prostate w/o Lower Urinary Tract Symptoms
 ;;^UTILITY(U,$J,358.3,6154,1,4,0)
 ;;=4^N40.0
 ;;^UTILITY(U,$J,358.3,6154,2)
 ;;=^5015689
 ;;^UTILITY(U,$J,358.3,6155,0)
 ;;=N42.89^^40^384^32
 ;;^UTILITY(U,$J,358.3,6155,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6155,1,3,0)
 ;;=3^Prostate Disorders NEC
 ;;^UTILITY(U,$J,358.3,6155,1,4,0)
 ;;=4^N42.89
 ;;^UTILITY(U,$J,358.3,6155,2)
 ;;=^270425
 ;;^UTILITY(U,$J,358.3,6156,0)
 ;;=N41.9^^40^384^23
 ;;^UTILITY(U,$J,358.3,6156,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6156,1,3,0)
 ;;=3^Inflammatory Disease of Prostate,Unspec
 ;;^UTILITY(U,$J,358.3,6156,1,4,0)
 ;;=4^N41.9
 ;;^UTILITY(U,$J,358.3,6156,2)
 ;;=^5015694
 ;;^UTILITY(U,$J,358.3,6157,0)
 ;;=N43.3^^40^384^22
 ;;^UTILITY(U,$J,358.3,6157,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6157,1,3,0)
 ;;=3^Hydrocele,Unspec
 ;;^UTILITY(U,$J,358.3,6157,1,4,0)
 ;;=4^N43.3
 ;;^UTILITY(U,$J,358.3,6157,2)
 ;;=^5015700
 ;;^UTILITY(U,$J,358.3,6158,0)
 ;;=N47.1^^40^384^31
 ;;^UTILITY(U,$J,358.3,6158,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6158,1,3,0)
 ;;=3^Phimosis
 ;;^UTILITY(U,$J,358.3,6158,1,4,0)
 ;;=4^N47.1
 ;;^UTILITY(U,$J,358.3,6158,2)
 ;;=^93340
 ;;^UTILITY(U,$J,358.3,6159,0)
 ;;=N47.2^^40^384^30
 ;;^UTILITY(U,$J,358.3,6159,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6159,1,3,0)
 ;;=3^Paraphimosis
 ;;^UTILITY(U,$J,358.3,6159,1,4,0)
 ;;=4^N47.2
 ;;^UTILITY(U,$J,358.3,6159,2)
 ;;=^90023
 ;;^UTILITY(U,$J,358.3,6160,0)
 ;;=N52.9^^40^384^16
